Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026)

Kestra Medical Technologies (KMTS) reported Return on Capital Employed of 53.17% for Q1 2026, up 9.33% quarter-over-quarter from 58.64% in Q4 2025.

Kestra Medical Technologies (KMTS) Return on Capital Employed (2025 - 2026) Analysis & Trends

Kestra Medical Technologies (KMTS) has 2 years of Return on Capital Employed data on file, last reported at 53.17% in Q1 2026.

Return on Capital Employed for Q1 2026 came in at 53.17%, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was 53.17% (changed N/A YoY), and the FY2025 annual result was 80.06%, changed N/A from the prior year.
Return on Capital Employed rose to 53.17% in Q1 2026 per KMTS's latest filing, from 58.64% in the prior quarter.
Over five years, Return on Capital Employed peaked at 46.96% in Q3 2025 and troughed at 64.91% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	17.54%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	5.02%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	25.95%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	18.63%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	19.44%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	4.68%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	12.74%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	13.02%
10	Kestra Medical Technologies	1.02 Bn	732.25 Mn	12.91 Mn	-53.17%

Download Data